MarketPeel
Insider Trading Intelligence
Pricing
…
MB

Michelle L. Basil

HAE
EVP AND GENERAL COUNSEL · HAEMONETICS CORP · CIK 0001699629
FILING MIX · LIFETIME36%/64%
BUYS
25
SELLS
45
TOTAL VALUE
$11.77M
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
68,829
AVG SELL PX
$82.38
TRADE KIND
SHOWING 70 / 70
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
27 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Michelle L. Basil, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d27+66.67%-1.98%-0.50%-1.48%-2.12%—
14d27+70.37%-1.25%-0.32%-0.93%-0.75%—
30d27+44.44%-0.85%+1.45%-2.30%-0.52%—
60d27+55.56%-2.78%+5.51%-8.29%-2.95%—
90d27+48.15%-1.67%+7.58%-9.25%-9.57%—
180d27+44.44%+5.11%+12.35%-7.25%-7.99%—
1y27+51.85%-7.58%+18.24%-25.82%-36.03%—
2y27+70.37%-5.18%+29.55%-33.25%-51.65%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HAE · 68,829 shares · as of May 15, 2026
017,29834,59751,89569,193202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 45 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
28,424——68,829May 15, 2026May 19, 2026 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
2,913$56.29$164.0K40,405May 15, 2026May 19, 2026 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
7,469$69.38$518.2K42,252May 30, 2025Jun 3, 2025 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
15,554——49,721May 30, 2025Jun 3, 2025 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
6,755——35,233May 16, 2025Jun 13, 2025 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
14,626——14,626May 16, 2025Jun 13, 2025 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
2,157$70.31$151.7K28,478May 16, 2025May 19, 2025 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
5,689——34,167May 16, 2025May 20, 2025 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
12,317——12,317May 16, 2025May 20, 2025 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
622$69.38$43.2K30,635May 15, 2025May 19, 2025 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
4,094$88.57$362.6K31,257May 29, 2024May 29, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
8,896$87.86$781.6K35,351May 29, 2024May 29, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
11,758$95.73$1.13M44,247May 28, 2024May 29, 2024 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
24,748——56,005May 28, 2024May 29, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
1,604$95.08$152.5K31,257May 20, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
4,178——32,861May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
1,073$95.00$101.9K29,352May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
9,183——9,183May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
669$95.73$64.0K28,683May 17, 2024May 21, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE10b5-1
10b5-1 plan
985$96.14$94.7K30,425May 16, 2024May 17, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
446$94.80$42.3K31,410May 16, 2024May 17, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
416$96.49$40.1K31,856May 15, 2024May 17, 2024 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
197$89.05$17.5K32,272Oct 20, 2023Oct 24, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
3,541$83.34$295.1K32,469May 18, 2023May 19, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
446$89.21$39.8K36,010May 16, 2023May 17, 2023 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
9,502——9,502May 15, 2023May 17, 2023 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
4,205——36,456May 15, 2023May 17, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
204$88.16$18.0K32,251May 12, 2023May 16, 2023 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
180$80.39$14.5K32,455Oct 24, 2022Oct 26, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
4,213——0Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
3,464——0Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASE
EVP and General Counsel
4,213$41.64$175.4K43,072Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
11,448$78.36$897.1K32,635Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASE
EVP and General Counsel
1,011$56.57$57.2K44,083Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASE
EVP and General Counsel
3,464$38.43$133.1K38,859Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
1,011——12,553Sep 19, 2022Sep 21, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASE
EVP and General Counsel
14,231$41.64$592.6K66,020Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
14,231——4,213Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
27,769$77.76$2.16M41,424Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASE
EVP and General Counsel
3,173$56.57$179.5K69,193Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASE
EVP and General Counsel
11,154$38.43$428.6K51,789Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
11,154——3,464Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
6,029$78.50$473.3K35,395Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
3,173——13,564Sep 15, 2022Sep 19, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
277$62.60$17.3K40,635Jun 13, 2022Jun 15, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
3,258$59.10$192.5K40,912May 19, 2022May 23, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
196$56.10$11.0K38,094May 16, 2022May 18, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
14,208——14,208May 16, 2022May 18, 2022 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
6,076——44,170May 16, 2022May 18, 2022 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
120$71.93$8.6K38,290Oct 25, 2021Oct 27, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
195$59.87$11.7K38,410Jun 14, 2021Jun 16, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
442$55.09$24.3K38,605Jun 7, 2021Jun 9, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
220$55.19$12.1K39,047May 19, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
17,677——39,267May 18, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
6,187——21,590May 18, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
16,737——16,737May 18, 2021May 20, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
204$55.97$11.4K15,403May 17, 2021May 18, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
385$120.07$46.2K15,607Mar 8, 2021Mar 10, 2021 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
181$106.58$19.3K15,992Oct 23, 2020Oct 26, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
5,175$90.32$467.4K24,434Jun 16, 2020Jun 16, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
1,300$92.14$119.8K16,173Jun 16, 2020Jun 16, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
6,961$91.34$635.8K17,473Jun 16, 2020Jun 16, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
10,578$87.71$927.8K29,609Jun 15, 2020Jun 16, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
203$89.29$18.1K40,187Jun 12, 2020Jun 16, 2020 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
24,014——40,390Jun 12, 2020Jun 16, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
687$97.03$66.7K16,376Jun 8, 2020Jun 10, 2020 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
9,821——9,821May 18, 2020May 19, 2020 ↗View →
HAE
HAEMONETICS CORP
PURCHASEGRANT
Stock grant
2,902——17,063May 18, 2020May 19, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
203$100.44$20.4K14,161May 15, 2020May 19, 2020 ↗View →
HAE
HAEMONETICS CORP
SALE
EVP and General Counsel
395$98.00$38.7K14,364Mar 9, 2020Mar 10, 2020 ↗View →
Other insiders · HAE
Loading peer insiders…
About this filer
CIK 0001699629
ROLE
EVP and General Counsel
PRIMARY
HAE
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001699629DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback